IMMP
Price
$1.65
Change
+$0.03 (+1.85%)
Updated
Apr 24, 02:19 PM (EDT)
Capitalization
227.13M
34 days until earnings call
XFOR
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Apr 23 closing price
Capitalization
35.25M
14 days until earnings call
Ad is loading...

IMMP vs XFOR

Header iconIMMP vs XFOR Comparison
Open Charts IMMP vs XFORBanner chart's image
Immutep
Price$1.65
Change+$0.03 (+1.85%)
Volume$12.83K
Capitalization227.13M
X4 Pharmaceuticals
Price$0.20
Change-$0.00 (-0.00%)
Volume$1.64M
Capitalization35.25M
IMMP vs XFOR Comparison Chart
Loading...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMMP vs. XFOR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMP is a StrongBuy and XFOR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (IMMP: $1.62 vs. XFOR: $0.20)
Brand notoriety: IMMP and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMP: 99% vs. XFOR: 99%
Market capitalization -- IMMP: $227.13M vs. XFOR: $35.25M
IMMP [@Biotechnology] is valued at $227.13M. XFOR’s [@Biotechnology] market capitalization is $35.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMP’s FA Score shows that 0 FA rating(s) are green whileXFOR’s FA Score has 0 green FA rating(s).

  • IMMP’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, XFOR is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMP’s TA Score shows that 5 TA indicator(s) are bullish while XFOR’s TA Score has 5 bullish TA indicator(s).

  • IMMP’s TA Score: 5 bullish, 3 bearish.
  • XFOR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, XFOR is a better buy in the short-term than IMMP.

Price Growth

IMMP (@Biotechnology) experienced а +11.72% price change this week, while XFOR (@Biotechnology) price change was +3.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

IMMP is expected to report earnings on Aug 27, 2025.

XFOR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMP($227M) has a higher market cap than XFOR($35.3M). IMMP YTD gains are higher at: -25.346 vs. XFOR (-72.560). XFOR has higher annual earnings (EBITDA): -7.74M vs. IMMP (-43.83M). IMMP has more cash in the bank: 159M vs. XFOR (135M). IMMP has less debt than XFOR: IMMP (1.69M) vs XFOR (78.2M). XFOR has higher revenues than IMMP: XFOR (1.12M) vs IMMP (0).
IMMPXFORIMMP / XFOR
Capitalization227M35.3M643%
EBITDA-43.83M-7.74M566%
Gain YTD-25.346-72.56035%
P/E RatioN/A3.10-
Revenue01.12M-
Total Cash159M135M118%
Total Debt1.69M78.2M2%
FUNDAMENTALS RATINGS
IMMP vs XFOR: Fundamental Ratings
IMMP
XFOR
OUTLOOK RATING
1..100
257
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
9393
PRICE GROWTH RATING
1..100
8496
P/E GROWTH RATING
1..100
10085
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XFOR's Valuation (42) in the Biotechnology industry is somewhat better than the same rating for IMMP (84). This means that XFOR’s stock grew somewhat faster than IMMP’s over the last 12 months.

IMMP's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as XFOR (100). This means that IMMP’s stock grew similarly to XFOR’s over the last 12 months.

IMMP's SMR Rating (93) in the Biotechnology industry is in the same range as XFOR (93). This means that IMMP’s stock grew similarly to XFOR’s over the last 12 months.

IMMP's Price Growth Rating (84) in the Biotechnology industry is in the same range as XFOR (96). This means that IMMP’s stock grew similarly to XFOR’s over the last 12 months.

XFOR's P/E Growth Rating (85) in the Biotechnology industry is in the same range as IMMP (100). This means that XFOR’s stock grew similarly to IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMMPXFOR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 16 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
IMMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSCPX54.73N/A
N/A
Fidelity Select Consumer Discret Port
BIEAX22.96N/A
N/A
Brandes International Equity A
FSKLX12.19N/A
N/A
Fidelity SAI Intl Low Volatil Idx
LHCTX17.53N/A
N/A
Lord Abbett Health Care R5
TMLPX8.54N/A
N/A
Transamerica Energy Infrastructure I

IMMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with PRRUF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then PRRUF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
+5.88%
PRRUF - IMMP
43%
Loosely correlated
N/A
CALC - IMMP
38%
Loosely correlated
+0.66%
XFOR - IMMP
37%
Loosely correlated
-0.84%
ARCT - IMMP
31%
Poorly correlated
+3.78%
AXON - IMMP
31%
Poorly correlated
+3.82%
More

XFOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with IMMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
-0.84%
IMMP - XFOR
37%
Loosely correlated
+5.88%
XCUR - XFOR
34%
Loosely correlated
+0.88%
SPHDF - XFOR
34%
Loosely correlated
+6.61%
LRMR - XFOR
31%
Poorly correlated
-5.04%
CRDF - XFOR
30%
Poorly correlated
-4.10%
More